Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report. - Suppr | 超能文献

Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.

作者信息

Bruckner H W, Pagano M, Falkson G, Creech R, Arseneau J C, Horton J, Brodovsky H, Davis T E, Slayton R W, Greenspan E

出版信息

Cancer Treat Rep. 1979 Feb;63(2):297-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.

Cancer Treat Rep. 1979 Feb;63(2):297-9.

2

Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.

Cancer Treat Rep. 1979 Feb;63(2):289-95.

3

[A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].

Lijec Vjesn. 1982 Mar-Apr;104(3-4):120-2.

4

[Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate].晚期卵巢癌化疗的对照前瞻性研究——环磷酰胺单药化疗与阿霉素、环磷酰胺、5-氟尿嘧啶和甲氨蝶呤联合化疗的对比

Lijec Vjesn. 1987 Jun;109(6):230-4.

5

Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.

Neth J Med. 1979;22(2):38-44.

6

Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.

Natl Cancer Inst Monogr. 1975 Oct;42:145-8.

7

Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.

N Engl J Med. 1978 Dec 7;299(23):1261-6. doi: 10.1056/NEJM197812072992301.

8

Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.

Cancer Treat Rep. 1977 May-Jun;61(3):355-7.

9

Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.

Cancer Treat Rep. 1979 Feb;63(2):281-8.

10

Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.美法仑、5-氟尿嘧啶和甲氨蝶呤联合与序贯治疗晚期卵巢癌的比较

Can Med Assoc J. 1980 Sep 6;123(5):365-71.

引用本文的文献

1

Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group.晚期卵巢癌的化疗。晚期卵巢癌试验组。

Cochrane Database Syst Rev. 2000(2):CD001418. doi: 10.1002/14651858.CD001418.

2

Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.美法仑、5-氟尿嘧啶和甲氨蝶呤联合与序贯治疗晚期卵巢癌的比较

Can Med Assoc J. 1980 Sep 6;123(5):365-71.

3

Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.

Invest New Drugs. 1989 Jul;7(2-3):255-60. doi: 10.1007/BF00170870.

4

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.晚期卵巢癌的化疗：随机临床试验综述。晚期卵巢癌试验协作组

BMJ. 1991 Oct 12;303(6807):884-93. doi: 10.1136/bmj.303.6807.884.